Navigation Links
Frederick Innovative Technology Center, Inc. – Success Story

Rare blood disorders are on VERALOX Therapeutics Inc.’s “hit” list. The company, a small molecule drug discovery and development firm based in the Frederick Innovative Technology Center, Inc. (FITCI), launched in September 2017 with a mission to develop a first-in-class therapeutic targeting rare immune-mediated blood disorders, beginning with heparin-induced thrombocytopenia (HIT) and HIT with thrombosis (HITT). These life-threatening diseases have a high mortality rate and often require limb amputations due to complications. The drug, VLX-1005, is the only therapeutic in development that strikes at the source of HITT and has performed impressively in clinically relevant animal models. Additionally, it has demonstrated preservation of insulin secretion and promotion of beta cell survival in newly-diagnosed type I diabetes patient samples, providing significant opportunities for market expansion into diabetes.

David Maloney, PhD, is one of VERALOX Therapeutics’ founders and its Chief Scientific Officer. Dr. Maloney led development of the drug during his tenure at the National Institutes of Health (NIH). He says the project is a work of passion. “I’ve dedicated a good part of my career to this quest and taking it forward is a natural step. It’s both exciting and humbling to think about how many lives could be improved by this therapy.”

Cofounders Matthew Boxer, PhD, and Jeffrey Strovel, PhD, concur readily. Dr. Strovel notes that HIT/HITT is classified as an “orphan” disease, affecting around 20,000 patients each year, but the cause is a personal imperative. “My father almost died of this disease. It damaged him and hurt his quality of life for his remaining years.”

The trio recently obtained exclusive patent rights for the drug candidate from four institutions: NIHNational Center for Advancing Translational Sciences, Eastern Virginia Medical School (EVMS), University of California Santa Cruz and Thomas Jefferson University. EVMS is in charge of patent landscape and licensing. The emerging company will be working with Dr. Mike Holinstat, Professor of Cardiovascular Medicine and Surgery at the University of Michigan, to advance their lead candidate through preclinical animal models and has also named their scientific advisory board, including leading clinicians and experts in the fields of HIT, hematology, pathology and biochemistry.

Gowthami Arepally M.D.- Professor of Medicine, Division of Hematology, Duke University Medical Center and the Medical Director of Therapeutic Apheresis at Duke.

Adam Cuker M.D.- Assistant Professor of Medicine, Pathology department and Laboratory Medicine, University of Pennsylvania Perelman School of Medicine.

Ted Holman Ph.D. - Professor of Chemistry and Biochemistry at the University of California Santa Cruz.

Steven McKenzie M.D., Ph.D. - Professor of Medicine, Thomas Jefferson University; Director, Cardeza Foundation for Hematologic Research; Director, Hematology; Associate Director, Hemophilia Center; Director, Hereditary Anemias Program.

Anand Padmanabhan M.D., Ph.D. - Department of Pathology at the Medical College of Wisconsin and Medical Sciences Institute of the Blood Center of Wisconsin.

FITCI President Kathie Callahan Brady is also an advisor. She says, VERALOX Therapeutics is a classic example of how accelerators and entrepreneurship go hand-in-hand. “The three principals of VERALOX, Doctors Boxer, Strovel and Maloney, were at the pinnacle of careers they worked hard to achieve but they decided to leave those stable jobs and take a grand leap into starting their own business because they are devoted to the cause. They have a singular vision that drives them forward and the motivation to make a positive impact on the world around them. Signing this exclusive license and gathering such prestigious board members are significant milestones. It’s the seed of potential sprouting before us.”

Read the full story at

Source: PRWeb
Copyright©2018 Vocus, Inc.
All rights reserved

Related medicine news :

1. Shady Grove Fertility Opens New Full-Service Office in Fredericksburg, Virginia and Welcomes Reproductive Endocrinologist, Nancy Durso, M.D. to the Practice
2. Serenity Natural Health Center LLC Co-owner is First Certified Medical Reiki Master in Frederick
3. Heaven On Earth, ColeKutz and 36 vendors give back to Frederick community at 2nd Annual Love Yourself Bazaar
4. Strategic Capital Partners Feeding Frederick Economy
5. UnitedHealthcare to Host 96 Hour Virtual Job Fair for Jobs in Frederick
6. Anytime Fitness Announces its Grand Opening at Whittier Lakefront in Frederick, MD
7. The Stephen Frederick Agency Joins the Feeding Texas Organization in Charity Drive to Stamp Out Hunger in Austin
8. Dr. Frederick Weniger Wins 8th Year in a Row - Best of Bluffton 2016
9. Dr. Frederick Weniger's Article Published in Aesthetic Surgery Journal
10. Join Dr. Frederick Weniger for In-House Seminar on March 3rd, 2016 at 5:30 p.m.
11. Mystic Buddha Publishing House Presents Valentine's Day Tips on the Forms of Love from Blue Skies Buddha, the Biography of Rama – Dr. Frederick Lenz
Post Your Comments:
(Date:6/20/2019)... (PRWEB) , ... June 20, 2019 , ... ... cycle management and IT services, announced that Angel Rosa has been appointed as ... leadership experience in developing and implementing new services, growing and nurturing high performing ...
(Date:6/19/2019)... ... June 19, 2019 , ... ... faith-based organizations, private institutions, media, and government joined Global Health Council (GHC) ... to improve universal access to water, sanitation, and hygiene (WASH) in healthcare ...
(Date:6/19/2019)... ... June 19, 2019 , ... A legal-medical partnership , on behalf ... filed class action lawsuits in 34 of the 48 states reporting hospital ... are an array of pharmaceutical manufacturers, distributors and retailers, all of whom, according to ...
(Date:6/19/2019)... ... ... Ovation® Fertility scientists have been invited to present four pieces of research at ... in Vienna, June 23-26, 2019. , Ovation’s oral presentation about the use of artificial ... for Oral Presentation and the Fertility Society of Australia Exchange Award., ...
(Date:6/18/2019)... ... June 18, 2019 , ... NeoTract, ... in the field of urology, today announced that Aaron Berger, MD, Associated Urological ... Excellence. The designation recognizes that Dr. Aaron Berger has achieved a high level ...
Breaking Medicine News(10 mins):
(Date:6/20/2019)... (PRWEB) , ... June 20, ... ... today the opening of MedMark Treatment Centers Columbus East, its first opioid ... counseling services for adults. The clinic, located at 1805 E. Main Street, ...
(Date:6/20/2019)... ... June 20, 2019 , ... ERT, a global data and ... scientific and technological experts will present a series of innovative and educational live ... in San Diego, June 23-27. , ERT’s industry-recognized thought leaders will share ...
(Date:6/19/2019)... ... 19, 2019 , ... Cardiovascular diseases remain the number one ... deaths (17.9 million per year), and are the most expensive condition to treat. ... treatment and real-time visualization of cardiac anomalies and subsequent therapy more effective. Artificial ...
Breaking Medicine Technology: